Jefferies Reiterates a 'Buy' on Medivation (MDVN); Xtandi Approved Early
Get Alerts MDVN Hot Sheet
Price: $81.44 --0%
Rating Summary:
12 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 14 | New: 22
Rating Summary:
12 Buy, 17 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 14 | New: 22
Join SI Premium – FREE
Jefferies reiterates a 'Buy' on Medivation (NASDAQ: MDVN) price target of $122.00 (from $113.00).
Analyst, Biren Amin, said, "Xtandi (enzalutamide) approval came ~3 months ahead of its November PDUFA date, and a slight positive on ~1 add’l qtr of sales. The label was generally in-line with launch price at a 28% premium over Zytiga. We continue to believe in strong Xtandi adoption as a potentially better AR inhibitor over Zytiga."
FY12 EPS estimate lowered from (1.22) to (1.45), but FY13 raised from (2.70) to (2.60)
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $104.86 yesterday.
Analyst, Biren Amin, said, "Xtandi (enzalutamide) approval came ~3 months ahead of its November PDUFA date, and a slight positive on ~1 add’l qtr of sales. The label was generally in-line with launch price at a 28% premium over Zytiga. We continue to believe in strong Xtandi adoption as a potentially better AR inhibitor over Zytiga."
FY12 EPS estimate lowered from (1.22) to (1.45), but FY13 raised from (2.70) to (2.60)
For an analyst ratings summary and ratings history on Medivation click here. For more ratings news on Medivation click here.
Shares of Medivation closed at $104.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- China Resources Beer Holdings Co Ltd. (291:HK) (CRHKY) PT Raised to HK$44.67 at Jefferies
- Silvercrest Asset Management (SAMG) PT Lowered to $20 at Singular Research
- Omega Healthcare Investors (OHI) PT Raised to $32 at Citi
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT Change, FDARelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!